tirzepatide gip analog Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Designing a dual GLP-1R/GIPR agonist

A 2 mL reconstitution volume yields a concentration of 2,500 mcg/mL of each peptide component (5,000 mcg/mL total peptide)

My Account 0 Cart $0.00 Shopping Cart Your cart is currently empty

doi: 10.1007/s12011-021-02662-w 84 MirzaieSZirak-KhattabFHosseiniSADonyaei-DarianH

Priority Applications (5) Applications Claiming Priority (2) Publications (1) Family ID=88518003 Family Applications (1) Country Status (7) Cited By (5) Families Citing this family (3) Citations (5) Family Cites Families (9) 2023 2023-04-28 CN CN202380037101.3A patent/CN120129529A/en active Pending 2023-04-28 US US18/849,043 patent/US20250205311A1/en active Pending 2023-04-28 WO PCT/IB2023/054435 patent/WO2023209662A1/en not_active Ceased 2023-04-28 EP EP23795768.3A patent/EP4514376A4/en active Pending 2023-04-28 TW TW112116103A patent/TW202400219A/en unknown 2023-04-28 AU AU2023262714A patent/AU2023262714B2/en active Active 2023-04-28 CA CA3252426A patent/CA3252426A1/en active Pending

Membranes were blocked with 5% skim milk for 1 h at room temperature followed by incubation with a primary antibody at 4 C overnight